Resound Nexia vs Resound Vivia 9 60S microRIE

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, priced at $4,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.0/5, ranking #26 of 36 devices in the Prescription Hearing Aid category. The Nexia demonstrates clear strengths in specific performance areas. Feedback handling is excellent at 5.0/5, scoring 0.29 points above the category average—meaning users can expect reliable stability without whistling during typical daily activities. Own-voice comfort is also a highlight at 3.6/5, measuring 0.85 points above average, which may appeal to those bothered by their voice sounding hollow or boomy in other devices. However, the Nexia shows meaningful limitations in challenging listening environments. Speech in noise performance is low at 1.0/5, falling 0.96 points below the category average of 1.96/5. Speech in quiet scores 3.2/5—solid in absolute terms, though 0.11 points below the category average. Music streaming is mixed at 2.8/5, slightly above average but not a standout. At this price point, several alternatives in the same range deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. The Nexia may be best suited for users who prioritize own-voice comfort and feedback-free performance over speech clarity in noisy environments, and who value the Resound ecosystem's connectivity features including iPhone and Android streaming with hands-free capability.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.